249
22
25
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11541 | HCV-IN-30 | Others , HCV Protease | |
HCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons). | |||
T9577 | HCV-IN-31 | HCV Protease | |
HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM. | |||
T11539 | HCV-IN-29 | HCV Protease | |
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor. | |||
T32050 | HCV-371 | HCV 371 | |
HCV-371 is a potent selective HCV NS5B polymerase inhibitor that shows broad inhibitory activity against NS5B RDRP and no inhibitory activity against a set of human polymerases (including mitochondrial DNA polymerase γ a... | |||
TQ0090 | Nesbuvir | HCV-796 | HCV Protease |
Nesbuvir is a selective hepatitis C virus (HCV) nonstructural protein 5B (NS5B) RNA-dependent polymerase inhibitor.Nesbuvir has an IC50 of 9 nM against hepatocellular carcinoma cells containing 1b HCV replicons. | |||
T27530 | HCV-086 | HCV086 | |
HCV-086, a RNA-directed RNA polymerase (NS5B) inhibitor, is used for the treatment of HCV infection. | |||
T11540 | HCV-IN-3 | Others | |
HCV-IN-3 is a hepatitis C virus (HCV) NS3/4a protein inhibitor (IC50: 20 μM; Kd: 29 μM). | |||
T11548 | HCV-IN-7 | Others | |
HCV-IN-7 is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. | |||
TP1468 | HCV-IN-4 | ||
HCV-IN-4, a potent and orally active inhibitor of HCV NS5A, demonstrates significant efficacy against genotypes GT1a, GT2b, GT3a, and the GT1a mutations Y93H and L31V. Its half-maximal effective concentrations (EC90s) ar... | |||
T11548L | HCV-IN-7 hydrochloride | Others | |
HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake. | |||
T63566 | HCV-IN-33 | ||
HCV-IN-33 (Compound (S)-3i) is an inhibitor of HCV entry. | |||
T79626 | HCV-IN-44 | ||
HCV-IN-44 (compound 28) is an inhibitor of the HCV NS5B protein, efficacious in suppressing HCV virus replication and useful for researching HCV infection [1]. | |||
T63585 | HCV-IN-37 | ||
HCV-IN-37 is a potent inhibitor of HCV. HCV-IN-37 is able to persist in rat plasma after oral administration to rats at a single dose of 15 mg/kg. The high potency of the active derivative HCV-IN-37 is mainly driven by t... | |||
T63567 | HCV-IN-34 | ||
HCV-IN-34 is an orally active HCV entry inhibitor. HCV-IN-35 exhibits good antiviral efficacy (EC50: 0.010 μM, CC50 (half of the maximum cytotoxic concentration): 7.50 μM). | |||
T63396 | HCV-IN-38 | ||
HCV-IN-38 is a selective, potent, orally active hepatitis C virus (HCV) inhibitor with an EC50 value of 15 nM and an SI value of 431. HCV-IN-38 has a good safety profile and oral pharmacokinetics, exhibiting high anti-HC... | |||
T74625 | HCV-IN-41 | ||
HCV-IN-41 (compound 4), a potent inhibitor of the hepatitis C virus (HCV), demonstrates exceptional inhibitory effectiveness across different genotypes, with EC 50 values of 0.006762 nM for genotype 1b, 5.183 nM for 2a, ... | |||
T79625 | HCV-IN-43 | ||
HCV-IN-43 (compound 2), an HCV NS5B protein inhibitor, efficiently inhibits HCV virus replication and is utilized in the study of HCV infection [1]. | |||
T63406 | HCV-IN-35 | ||
HCV-IN-35 is a potent inhibitor of HCV and shows potential for infectious disease research. | |||
T63407 | HCV-IN-36 | ||
HCV-IN-36 is an orally active HCV entry inhibitor that exhibits good antiviral activity (EC50: 0.016 μM, CC50 (half of the maximum cytotoxic concentration): 8.78 μM). | |||
T64202 | HCV-IN-40 | ||
HCV-IN-39 (Compound 18a) is a potent, orally active nucleoside inhibitor of hepatitis C virus (HCV) that acts on the GT1a replicon (EC50: 0.259 μM), GT1b replicon (EC50: 0.434 μM) and GT1b CES1 replicon (EC50. 0.069 μM). | |||
T76518 | HCV Peptide (131-140) | ||
HCV Peptide (131-140) is a research-grade peptide utilized in the study of the hepatitis C virus (HCV) [1]. | |||
T76520 | HCV Peptide (257-266) | ||
HCV Peptide (257-266) is a peptide utilized in hepatitis C virus (HCV) research [1]. | |||
T76519 | HCV Peptide (35-44) | ||
HCV Peptide (35-44), a core protein of Hepatitis C Virus located at positions 35 to 44, functions as an HLA-A2-restricted CTL epitope and inhibits NK cell activity through two distinct mechanisms: directly through the KI... | |||
T76522 | HCV Core Protein (59-68) | ||
HCV Core Protein (59-68) is a peptide comprising residues 59-68 from the core protein of the Hepatitis C virus (HCV) [1]. | |||
T76523 | HCV Core Protein (107-114) | ||
HCV Core Protein (107-114), identified as the binding site within the region 101-118, is a minimally immunogenic fragment of the primary linear HCV core regions. This segment, comprising two residues that vary between ge... | |||
T76514 | HCV-1 e2 Protein (554-569) | ||
HCV-1 e2 Protein (554-569), a primary antigenic region within the Hepatitis C Virus envelope 2 (e2) protein, features a putative N-glycosylation site believed to impact the immune recognition of e2 [1]. | |||
T76516 | HCV-1 e2 Protein (484-499) | ||
HCV-1 e2 Protein (484-499) is a 16-amino acid peptide derived from the envelope 2 protein of the hepatitis C virus, identified in the sera of individuals possessing antibodies to HCV [1]. | |||
T80089 | HCV-1 e2 Protein (554-569) (TFA) | ||
HCV-1 e2 Protein (554-569) TFA, an antigenic segment of the hepatitis C virus envelope 2 (e2) protein, encompasses a potential N-glycosylation site implicated in modulating immune recognition of e2 [1]. | |||
T38237 | 2′-O-Methylcytidine | Nucleoside Antimetabolite/Analog , HCV Protease | |
2'-O-Methylcytidine is a nucleoside derivative and an inhibitor of hepatitis C virus (HCV) non-structural protein 5B (NS5B; IC50= 3.8 μM).1It inhibits HCV replication in a replicon assay (IC50= 21.2 μM). 1.Migliaccio, G.... | |||
T76521 | HCV NS4A Protein (18-40) (JT strain) | ||
HCV NS4A Protein (18-40) (JT strain) is a peptide derived from residues 18 to 40 of the HCV NS4A protein. It enhances the catalytic efficiency of NS3 protease [1]. | |||
T3489 | Dasabuvir | ABT-333 | HCV Protease |
Dasabuvir (ABT-333) is a non-nucleoside inhibitor of the hepatitis C virus (HCV) non-structural protein 5B (NS5B), an RNA-dependent RNA polymerase, with potential activity against HCV. Upon administration and after intra... | |||
T25268 | Coblopasvir | Others | |
Coblopasvir is a pan-genotypic non-structural protein 5A (NS5A) inhibitor. It can be used to study chronic hepatitis C virus infection. | |||
T4197 | HZ-1157 | HZ1157,DHFR-inhibitor | HCV Protease |
HZ-1157 (DHFR-inhibitor) is a hepatitis C virus (HCV) inhibitor with inhibitory activities toward HCV NS3/4A protease. | |||
T1822 | Clemizole | HCV Protease , Histamine Receptor | |
Clemizole is an H1 histamine receptor antagonist, can inhibit NS4B's RNA binding and hepatitis C virus (HCV) replication. | |||
T17190 | U18666A | Others , HCV Protease | |
U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus. | |||
T19862 | Voxilaprevir | HCV Protease | |
Voxilaprevir is an inhibitor of hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease. | |||
T5126 | Glecaprevir | ABT-493 | HCV Protease , SARS-CoV |
Glecaprevir (ABT-493) is an HCV NS3/4A protease inhibitor, (IC50s: 3.5-11.3 nM). | |||
T4547 | Grazoprevir | MK-5172 | HCV Protease , SARS-CoV |
Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 nM (gt1a), 0.08 nM (gt2a), 0.90 nM (gt3a), 0.01 nM (gt1b), ... | |||
T5938 | 4-Phenoxybenzylamine | HCV Protease | |
4-Phenoxybenzylamine inhibits the function of the NS3 protein by stabilizing an inactive conformation with an IC50 of about 500 μM against HCV NS3/4a . | |||
T4474 | Asunaprevir | BMS-650032 | HCV Protease , SARS-CoV |
Asunaprevir (BMS-650032) is an effective hepatitis C virus (HCV) NS3 protease inhibitor. | |||
T1822L | Clemizole hydrochloride | HCV Protease , Histamine Receptor | |
Clemizole hydrochloride is an antagonist for H1 histamine receptor. According to the research, Clemizole hydrochloride can inhibit hepatitis C virus (HCV) replication and NS4B's RNA binding. | |||
T15573 | Inarigivir soproxil | SB9200 | HCV Protease |
Inarigivir soproxil (SB9200) is an agonist of innate immunity. It also displays effective antiviral activity against resistant hepatitis C virus (HCV) variants (EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype ... | |||
T16088 | MK-0608 | HCV Protease | |
MK-0608 is an orally bioavailable HCV replication inhibitor in vitro(EC50 = 0.3 μM and EC90=1.3 μM in the subgenomic-replicon assay). | |||
T25268L | Coblopasvir dihydrochloride | Coblopasvir dihydrochloride(1312608-46-0 Free base) | HCV Protease |
Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor. | |||
T4988 | Boceprevir | SCH 503034,EBP 520 | HCV Protease , SARS-CoV |
Boceprevir (SCH 503034) is a novel, potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with Ki of 14 nM in both enzyme assay and EC90 of 350 nM in cell-based replicon assay. | |||
T9567 | Samatasvir | ATOLIHZIXHZSBA-BTSKBWHGSA-N,IDX719 | HCV Protease |
Samatasvir (ATOLIHZIXHZSBA-BTSKBWHGSA-N) is a pan-genotypic inhibitor of the HCV non-structural protein 5A. | |||
T22394 | Paritaprevir | ABT450,ABT-450,Veruprevir | HCV Protease |
Paritaprevir (ABT450) is an inhibitor of non-structural protein 3/4A protease with EC50 values of 1 and 0.21 nM for HCV 1a and HCV 1b, respectively. | |||
T4544 | Elbasvir | MK-8742 | HCV Protease |
Elbasvir (MK-8742) is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection. | |||
T6190 | Telaprevir | VX-950,LY-570310,Incivek,MP-424 | HCV Protease , SARS-CoV |
Telaprevir (Incivek) (VX-950) is an effective inhibitor of HCV NS3-4A serine protease (IC50: 0.35 μM). | |||
T0013 | Mecarbinate | Dimecarbine,Dimecarbin | HCV Protease |
Mecarbinate (Dimecarbin) is arbidol hydrochloride's chemical intermediate. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5S1598 | Mulberroside C | Antioxidant , HCV Protease | |
1. Mulberroside C has antioxidant activity. | |||
T2770 | Gentiopicroside | Gentiopicrin | P450 , HCV Protease |
Gentiopicroside (Gentiopicrin), a naturally occurring iridoid glycoside, extracted from Gentiana manshurica Kitag, inhibits P450 activity, with an IC50 and a Ki of 61 μM and 22.8 μM for CYP2A6; has antianti-inflammatorya... | |||
TN2089 | Platycodin D3 | HCV Protease , NF-κB | |
Platycodin D3 is a NF-κB inhibitor, it could as expectorants in diverse inflammatory pulmonary diseases, it can regulate the production and secretion of airway mucin; it can significantly enhance mitogen- and OVA-induced... | |||
T3810 | Saikosaponin B2 | Others , HCV Protease | |
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 μM) induces differentiation of B16 melanoma cells, with... | |||
T3001 | Honokiol | NSC 293100 | ERK , HCV Protease , MEK , Akt , Autophagy |
Honokiol (NSC-293100) is the active principle of magnolia extract. It inhibits the activation of Akt and enhances the phosphorylation of ERK1/ERK2. | |||
T7607 | PSI-6130 | R 1656 | HCV Protease |
PSI-6130 (R 1656) is a potent and selective HCV NS5B polymerase inhibitor. PSI-6130 inhibits HCV replication with a mean IC50 of 0.6 μM. | |||
T3821 | Deapioplatycodin D | Deapi-platycodin D,DesapioplatycodinD | Others , HCV Protease |
Deapioplatycodin D and platycodin D can regulate the production and secretion of airway mucin and, at least in part, explains the traditional use of aqueous extract of APG as expectorants in diverse inflammatory pulmonar... | |||
T0392 | Artemisinin | Qinghaosu,Artemisinine,Qinghaosu,NSC 369397,Artemisinine | HCV Protease , Ferroptosis , Akt , Parasite |
Artemisinin (Qinghaosu) is an ancient Chinese herbal therapy for malarial fevers which has been recently found to have potent activity against many forms of malarial organisms, including chloroquine-resistant Plasmodium ... | |||
TN6732 | Oenothein B | Apoptosis , HCV Protease , Antibacterial , Antifungal | |
Oenothein B is a specific inhibitor of poly(ADP-ribose) glycohydrolase. Oenothein B shows antioxidant, anti-inflammatory, antifungal, anti-HCV, and antitumor properties. | |||
T1188 | Mizoribine | Bredinin,NSC 289637,HE 69 | HCV Protease , SARS-CoV , Tyrosinase |
Mizoribine (NSC-289637) belongs to the family of 1-Ribosyl-imidazolecarboxamides. Mizoribine has been investigated for the treatment of Rheumatoid Arthritis. | |||
T7203 | Oglufanide | L-Glutamyl-L-tryptophan,H-Glu-Trp-OH | VEGFR , HCV Protease , Endogenous Metabolite |
Oglufanide (H-Glu-Trp-OH) is a naturally occurring thymic immunomodulator,and inhibits vascular endothelial growth factor (VEGF). | |||
TN1034 | Sennidin B | HCV Protease , transporter , Akt , PI3K | |
Sennidin B stimulates glucose incorporation in rat adipocytes. | |||
TN1033 | Sennidin A | HCV Protease , transporter , Akt , PI3K | |
Sennidin A, has two hydroxyanthraquinone-like moieties, exerts inhibition on NS3 helicase with IC50 values of 0.8 μM. | |||
T38375 | Pseudane IX | 2-nonyl-4-hydroxyquinoline,2-nonyl-1H-quinolin-4-one,2-nonyl-4(1h)-quinolone | HCV Protease |
Pseudane IX (2-nonyl-1H-quinolin-4-one) reduces infection of Huh 7.5 cells by hepatitis C virus (HCV) with an IC50 of 1.4 μg/ml. | |||
T2774 | Lycorine hydrochloride | Licorine hydrochloride,Galanthidine hydrochloride,Narcissine hydrochloride,Lycorine chloride,Amarylline hydrochloride | Virus Protease , HCV Protease , Antibacterial , Autophagy |
Lycorine hydrochloride (Narcissine hydrochloride) is VE-cadherin inhibitor,and has IC50 of 1.2μM in Hey1B cell.It is an HCV inhibitor with strong activity. | |||
TN6508 | Trachelogenin | (-)-Trachelogenin | Virus Protease , c-Myc , HCV Protease , Wnt/beta-catenin |
Trachelogenin ((-)-Trachelogenin), isolated from Combretum fruticosum, is an HCV entry inhibitor with anti-proliferative effects. Its mechanism is related to affecting the phosphorylation of key proteins such as β-Cateni... | |||
TN1138 | γ-Fagarine | gamma-Fagarine | HCV Protease |
gamma-Fagarine possesses moderate levels of anti-HCV activities with IC50 values being 20.4 ± 0.4 ug/ml, respectively. It has sister chromatid exchanges (SCEs)-inducing activity | |||
TN3809 | Dehydrojuncusol | HCV Protease | |
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patie... | |||
T16165 | Myriocin | ISP-I,Thermozymocidin | HCV Protease , Antifungal |
Myriocin (Thermozymocidin), a metabolite derived from Myriococcum albomyces, is a serine-palmitoyltransferase (SPT) inhibitor with potential antitumour, anticancer, and antiparasitic activities.Myriocin inhibits tumour g... | |||
TN5079 | Sulochrin | HCV Protease , Antifection | |
Sulochrin shows antifungal and antibacterial activities, it can inhibit hepatitis C virus (HCV) infection in a dose-dependent manner without any apparent cytotoxicity up to 50 uM. Sulochrin has an inhibitory activity to ... | |||
TN4404 | Ladanein | HCV Protease | |
Ladanein is a phytochemicals inhibitor that is known to disrupt the interactions of core and other hepatitis C virus (HCV) proteins.Ladanein possesses free radicals DPPH and ABTS +.scavenging activity, it also displays m... | |||
TN3438 | Arborinine | HCV Protease , Antifection | |
Arborinine shows mild in vitro antibacterial activity, it possesses moderate levels of anti-hepatitis C virus(HCV) activities with the IC50 values being 6.4 ± 0.7 ug/ml. Arborinine shows antifeedant activity against Spod... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01564 | Hepatitis C virus (HCV-1a) E2 Protein (His) | HCV | HEK293 |
TMPY-04135 | Hepatitis C virus Envelope Glycoprotein E1/HCV-E1 (subtype 1b, strain HC-J4) Protein (His) | HCV | HEK293 |
TMPY-00296 | Hepatitis C virus (HCV) (serotype 1c,isolate HC-G9) E2 Protein (His) | HCV | HEK293 |
TMPY-05166 | Hepatitis C virus (HCV) (serotype 1b, isolate HC-J4) Envelope/E2 Protein (His) | HCV | HEK293 |
TMPY-00323 | Hepatitis C virus (HCV-1a) NS3 protease/helicase immunodominant region Protein (aa 1356-1459, GST) | HCV | E. coli |
HCV NS3 displays three enzymatic activities: serine protease, NTPase, and RNA helicase. HCV NS3 serine protease, in association with NS4A, is responsible for the cleavages of NS3-NS4A, NS4A-NS4B, NS4B-NS5A, and NS5A-NS5B... | |||
TMPJ-01273 | ACY3 Protein, Human, Recombinant (His) | Human | E. coli |
Aspartoacylase 3, also known as ACY3, N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming), Acylase III, Aminoacylase-3, Aspartoacylase-2, Aspartoacylase-2, HCV core-binding protein 1 and ASPA2, is a member ... | |||
TMPY-01032 | CD299 Protein, Human, Recombinant (hFc) | Human | HEK293 |
C-type lectin domain family 4, member M, also known as DC-SIGNR and CLEC4M, is a type II integral membrane protein that is 77% amino acid identical to DC-SIGN, an HIV gp120-binding protein. Though the encoded gene locate... | |||
TMPY-03565 | Mannan Binding Lectin/MBL2 Protein, Human, Recombinant | Human | CHO |
MBL (mannose-binding lectin) is primarily a liver-derived collagen-like serum protein, which binds sugar structures on micro-organisms and dying host cells and is one of the four known mediators that initiate activation ... | |||
TMPH-01555 | IFITM1 Protein, Human, Recombinant (GST) | Human | E. coli |
IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against ... | |||
TMPY-02285 | Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Non-structural/NS2 Protein | H1N1 | E. coli |
Non-structural protein 2 (NS2) plays a crucial role in the hepatitis C virus (HCV) assembly. NS2 was predicted to be composed of three transmembrane (TM) segments. Hepatitis C virus (HCV) nonstructural protein 2 (NS2) is... | |||
TMPH-00848 | OASL Protein, Human, Recombinant (His) | Human | E. coli |
Does not have 2'-5'-OAS activity, but can bind double-stranded RNA. Displays antiviral activity against encephalomyocarditis virus (EMCV) and hepatitis C virus (HCV) via an alternative antiviral pathway independent of RN... | |||
TMPY-04231 | CD299 Protein, Human, Recombinant | Human | HEK293 |
C-type lectin domain family 4, member M, also known as DC-SIGNR and CLEC4M, is a type II integral membrane protein that is 77% amino acid identical to DC-SIGN, an HIV gp120-binding protein. Though the encoded gene locate... | |||
TMPH-01548 | IFI6 Protein, Human, Recombinant (B2M & His) | Human | E. coli |
Plays a role in apoptosis, negatively regulating the intrinsinc apoptotic signaling pathway and TNFSF10-induced apoptosis. However, it has also been shown to have a pro-apoptotic activity. Has an antiviral activity towar... | |||
TMPH-01604 | SLC7A5 Protein, Human, Recombinant (His & Myc & SUMO) | Human | E. coli |
The heterodimer with SLC3A2 functions as sodium-independent, high-affinity transporter that mediates uptake of large neutral amino acids such as phenylalanine, tyrosine, L-DOPA, leucine, histidine, methionine and tryptop... | |||
TMPH-01248 | ADAR Protein, Human, Recombinant (His & SUMO) | Human | E. coli |
Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translatio... | |||
TMPH-01249 | ADAR Protein, Human, Recombinant (GST) | Human | E. coli |
Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translatio... | |||
TMPH-00809 | Hepatitis C Genome polyprotein (His) | HCV | E. coli |
TMPY-04695 | CCL4 Protein, Rat, Recombinant (His) | Rat | Yeast |
CCL4 (C-C chemokine ligand 4), is a macrophage inflammatory protein with a chief effect in inflammation and immune-regulation, and was documented in cancer progression by promoting instability in the tumor environment. T... | |||
TMPY-02193 | GOLPH2/GOLM1 Protein, Human, Recombinant (His) | Human | HEK293 |
Golgi membrane protein 1, also known as Golgi membrane protein GP73, Golgi phosphoprotein 2, and GOLM1, is a protein that belongs to the GOLM1 / CASC4 family. GOLM1 is widely expressed. It is highly expressed in the colo... | |||
TMPY-00646 | CCL4 Protein, Human, Recombinant (His) | Human | Yeast |
CCL4 (C-C chemokine ligand 4), is a macrophage inflammatory protein with a chief effect in inflammation and immune-regulation, and was documented in cancer progression by promoting instability in the tumor environment. T... | |||
TMPH-01073 | CD81 Protein, Human, Recombinant (His & SUMO) | Human | E. coli |
Structural component of specialized membrane microdomains known as tetraspanin-enriched microdomains (TERMs), which act as platforms for receptor clustering and signaling. Essential for trafficking and compartmentalizati... | |||
TMPJ-01330 | CD299 Protein, Human, Recombinant (His & Flag) | Human | Human Cells |
CD299 is also known as DC-SIGNR and CLEC4M, is a type II integral membrane protein. DC-SIGNR exists as a homotetramer, and the tandem repeat domain, also called neck domain, mediates oligermerization. Multiple human DC-S... | |||
TMPY-04322 | Mannan Binding Lectin/MBL2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
MBL (mannose-binding lectin) is primarily a liver-derived collagen-like serum protein, which binds sugar structures on micro-organisms and dying host cells and is one of the four known mediators that initiate activation ... | |||
TMPY-00429 | Mannan Binding Lectin/MBL2 Protein, Mouse, Recombinant (mFc) | Mouse | HEK293 |
MBL (mannose-binding lectin) is primarily a liver-derived collagen-like serum protein, which binds sugar structures on micro-organisms and dying host cells and is one of the four known mediators that initiate activation ... | |||
TMPH-01556 | EIF2AK2 Protein, Human, Recombinant (His) | Human | Yeast |
IFN-induced dsRNA-dependent serine/threonine-protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) and plays a key role in the innate immune response to v... |